Social Media Use in Sickle Cell Patients

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03472300` - Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
Completed	`NCT04614935` - Adherence and Outcomes in Functional Constipation With a Constipation Action Plan	N/A
Completed	`NCT03799185` - Dyslipidemia Prevalence, Perception, Treatment, and Awareness in the Tunisian Population
Completed	`NCT04471701` - Italian Web-based Cross-sectional Survey on COVID-19

See also

Status

Clinical Trial

Phase

Active, not recruiting

NCT03472300 - Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals

Completed

NCT04614935 - Adherence and Outcomes in Functional Constipation With a Constipation Action Plan

N/A

Completed

NCT03799185 - Dyslipidemia Prevalence, Perception, Treatment, and Awareness in the Tunisian Population

Completed

NCT04471701 - Italian Web-based Cross-sectional Survey on COVID-19

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05182216
Study type	Observational
Source	University of Alabama at Birmingham
Contact
Status	Withdrawn
Phase
Start date	January 1, 2023
Completion date	December 31, 2023

Social Media Use in Sickle Cell Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms